D. E. Shaw & Co., Inc. Aptinyx Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.86 - $4.33 $128,802 - $195,005	-45,036 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $131,955 - $193,654	45,036 New	45,036 $156,000
Q3 2020 Nov 16, 2020	SELL	$3.05 - $4.99 $72,751 - $119,026	-23,853 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.99 - $4.4 $47,467 - $104,953	23,853 New	23,853 $99,000
Q2 2019 Aug 14, 2019	SELL	$2.95 - $4.38 $93,559 - $138,911	-31,715 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.99 - $19.33 $126,542 - $613,050	31,715 New	31,715 $128,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.